Longaeva Partners’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Longaeva Partners's MRNA Position: Q3 2026 in Review
Longaeva Partners opened a new position in Moderna (MRNA) in Q3 2026: 71,122 shares worth $13.7M. The stake represents 0.28% of the portfolio and ranks #89 among its holdings.
1,028 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- Longaeva Partners held 71,122 shares of Moderna worth $13.7M as of Q3 2026.
- Moderna was a new Longaeva Partners position in Q3 2026.
- Moderna made up 0.28% of Longaeva Partners's portfolio in Q3 2026, its #89 holding.
- 1,028 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on Longaeva Partners's 13F filing for Q3 2026, filed 16 Nov 2026.